Cargando…
FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma
Objective: This study aimed to validate FANCI as a potential marker for both prognosis and therapy in liver hepatocellular carcinoma. Method: FANCI expression data were acquired from GEPIA, HPA, TCGA, and GEO databases. The impact of clinicopathological features was analyzed by UALCAN. The prognosis...
Autores principales: | Hou, Yibo, Li, Jianing, Yu, Albert, Deng, Kexin, Chen, Jiawei, Wang, Zixian, Huang, Laiqiang, Ma, Shaohua, Dai, Xiaoyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266051/ https://www.ncbi.nlm.nih.gov/pubmed/37324186 http://dx.doi.org/10.7150/ijms.83760 |
Ejemplares similares
-
Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023) -
Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023) -
Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
por: Yu, Albert, et al.
Publicado: (2022) -
Correction: Yu et al. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy. Biosensors 2022, 12, 109
por: Yu, Albert, et al.
Publicado: (2022) -
miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis
por: Ye, Guanchao, et al.
Publicado: (2021)